Clinical Trials in Portland

Showing 381-400 of 10,048 trials

Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer

NCT02734290

The goal of this study is to establish the safety and tolerability of pembrolizumab when administered in combination with either of two chemotherapy regimens (weekly paclitaxel or capecitabine) in unresectable/metastatic triple negative breast cancer (MTNBC) patients.

Triple Negative Breast Cancer

Providence Health & Services29 participantsStarted Feb 2016

Los Angeles, California, United States • Portland, Oregon, United States

RECRUITINGPhase 3< 1 mile

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

NCT07351045

The purpose of this study is to assess the efficacy and safety of enicepatide, a dual glucagon like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist (RA), at multiple doses compared with placebo for weight management in participants without Type 2 diabetes mellitus (T2DM) who have obesity or overweight with at least one weight-related comorbidity.

Obesity or Overweight

Hoffmann-La Roche2,000 participantsStarted Mar 2026

Anniston, Alabama, United States • Tucson, Arizona, United States • San Diego, California, United States +25 more locations

Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Find Trials by Condition in Portland

Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy

A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Cancer Treatment

Clinical Outcomes and Patient Satisfaction With Use of the Amma System

EXtubation Related Complications - the EXTUBE Study (EXTUBE)

Evaluation of the Efficacy and Safety of LevoCept

Psilocybin for Major Depressive Disorder (MDD)

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

The Personal Patient Profile Decision Support for Patients With Bladder Cancer

Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

(PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis